Zambon Spa
Clinical trials sponsored by Zambon Spa, explained in plain language.
-
Inhaled cyclosporine aims to halt lung transplant rejection
Disease control CompletedThis Phase 3 trial tested whether adding inhaled liposomal cyclosporine A to standard care can improve lung function in 169 double lung transplant patients with chronic rejection. Participants inhaled the drug twice daily for 48 weeks. The main goal was to see if it slowed the de…
Phase: PHASE3 • Sponsor: Zambon SpA • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Inhaled cyclosporine shows promise for lung transplant rejection
Disease control CompletedThis Phase 3 trial tested whether adding inhaled liposomal cyclosporine A to standard care helps single lung transplant patients with chronic lung rejection. 62 adults who had a single lung transplant at least a year earlier and had signs of chronic rejection took part. The study…
Phase: PHASE3 • Sponsor: Zambon SpA • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Can NAC help you cough up mucus faster? new trial results are in
Symptom relief CompletedThis phase 3 trial tested whether the drug N-acetylcysteine (NAC) can thin mucus and make it easier to cough up in adults with respiratory infections like bronchitis or bronchiectasis. About 333 hospitalized patients in China received either NAC, another expectorant (ambroxol), o…
Phase: PHASE3 • Sponsor: Zambon SpA • Aim: Symptom relief
Last updated Jun 26, 2026 13:33 UTC